-+ 0.00%
-+ 0.00%
-+ 0.00%

GlucoTrack IDE submission enters FDA review for implantable blood glucose monitor

PUBT·05/26/2026 12:01:12
Listen to the news
GlucoTrack IDE submission enters FDA review for implantable blood glucose monitor
  • GlucoTrack submitted an Investigational Device Exemption application to the FDA, seeking clearance to start a U.S. clinical study for its implantable CBGM.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605260800PRIMZONEFULLFEED9726178) on May 26, 2026, and is solely responsible for the information contained therein.